Skip to main content
A

Abnova (Taiwan) Corporation — Investor Relations & Filings

Ticker · 4133 TW Professional, scientific and technical activities
Filings indexed 1,472 across all filing types
Latest filing 2025-11-24 Regulatory Filings
Country TW Taiwan
Listing TW 4133

About Abnova (Taiwan) Corporation

http://www.abnova.com

Abnova Corporation is a global leader in the high-throughput production of antibodies and recombinant proteins. By integrating industrial-scale manufacturing with IT-driven management systems, the company maintains one of the world's largest catalogs of biological reagents. Its core offerings encompass gene synthesis, cytogenetics, peptide services, and protein expression. Abnova provides comprehensive solutions for life science research, including custom antibody production, scale-up, and humanization. Recent technological expansions include the RNAutomation™ mRNA service, NanoAb™ services, and nanoCAR-T mRNA solutions. The company supports academic and industrial researchers across multidisciplinary fields with integrated assay development and advanced bioreagent tools.

Recent filings

Filing Released Lang Actions
114年11月法人說明會簡報 — 413320251121E001.pdf
Regulatory Filings
2025-11-24 Chinese
114年11月法人說明會簡報 — 413320251121M001.pdf
Regulatory Filings
2025-11-24 Chinese
114年11月法人說明會簡報
Regulatory Filings
2025-11-24 Chinese
本公司受邀參加凱基證券舉辦之線上法人說明會
Regulatory Filings
2025-11-24 Chinese
114年第3季財務報告書 — 202504_4133_AI3.pdf
Regulatory Filings
2025-11-11 Chinese
114年第3季財務報告書 — 202504_4133_AI1.pdf
Regulatory Filings
2025-11-11 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.